Table 23.

The distribution of plant families and genera used treat each disease and disease category in Peru, Mali, and the combined medicinal flora of the two areas. Those distributions with a significant difference based on a log-likelihood ratio test (G-test) are marked with a footnote, all other pairwise comparisons of categories or diseases are not significantly different.

	Mali				Peru				Combined
	Families		Genera		Families		Genera		Families		Genera
Disease	n	percent of present	n	percent of present	n	percent of present	n	percent of present	n	percent of present	n	percent of present
Parasitic	23	36.51%	38	16.89%	24	12.44%	27	2.37%	35b	17.59%	58cd	4.57%
Malaria	19	30.16%	32	14.22%	9	4.66%	9	0.79%	25	12.56%	39	3.07%
Trypanosomesa	13	20.63%	15	6.67%	15	7.77%	18	1.58%	22	11.06%	30	2.36%
Chagas	0	0.00%	0	0.00%	4	2.07%	5	0.44%	4	2.01%	13	1.02%
Leishmaniasis	0	0.00%	0	0.00%	11	5.70%	13	1.14%	11	5.53%	5	0.39%
Autoimmune	26	41.27%	40	17.78%	28	14.51%	39	3.43%	41	20.60%	75c	5.91%
Diabetes	15	23.81%	19	8.44%	19	9.84%	22	1.93%	32	16.08%	41	3.23%
Asthma	13	20.63%	17	7.56%	12	6.22%	12	1.05%	22	11.06%	28	2.20%
Eczema	17	26.98%	20	8.89%	9	4.66%	10	0.88%	23	11.56%	29	2.28%
Fibroids	20	31.75%	26	11.56%	12	6.22%	13	1.14%	26b	13.07%	36d	2.83%

^a Trypanosomes includes Chagas disease, leishmaniasis, and African sleeping sickness.

^b The combined plant families of Peru and Mali used to treat uterine fibroids and parasitic diseases had a significant difference with p = 0.01911

^c The combined plant genera of Peru and Mali used to treat autoimmune and parasitic diseases had a significant difference with p = 0.03987

^d The combined plant genera of Peru and Mali used to treat uterine fibroids and parasitic diseases had a significant difference with p = 0.04909